KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Other Accumulated Expenses (2016 - 2026)

Pfizer has reported Other Accumulated Expenses over the past 17 years, most recently at $20.1 billion for Q1 2026.

  • Quarterly Other Accumulated Expenses changed 0.46% to $20.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $20.1 billion through Mar 2026, changed 0.46% year-over-year, with the annual reading at $19.4 billion for FY2025, 1.46% down from the prior year.
  • Other Accumulated Expenses was $20.1 billion for Q1 2026 at Pfizer, up from $19.4 billion in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $24.6 billion in Q2 2022 and troughed at $16.1 billion in Q3 2023.
  • The 5-year median for Other Accumulated Expenses is $19.7 billion (2024), against an average of $19.8 billion.
  • Year-over-year, Other Accumulated Expenses soared 92.08% in 2022 and then crashed 32.49% in 2023.
  • A 5-year view of Other Accumulated Expenses shows it stood at $22.6 billion in 2022, then decreased by 9.0% to $20.5 billion in 2023, then dropped by 3.98% to $19.7 billion in 2024, then fell by 1.46% to $19.4 billion in 2025, then increased by 3.48% to $20.1 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Other Accumulated Expenses are $20.1 billion (Q1 2026), $19.4 billion (Q4 2025), and $19.5 billion (Q3 2025).